BioMarin Pharmaceutical (0HNC) Earnings Dates, Call Summary & Reports

2 Followers

Earnings Data

Estimated Report Date: Feb 24, 2027
Period Ending: 2026 (Q4)
Consensus EPS Forecast: 0.82
Last Year’s EPS: -0.24
Analyst Consensus: Moderate Buy

BioMarin Pharmaceutical (GB:0HNC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.

Daily Earnings Calendar >

GB:0HNC Q3 2026 Earnings Report

Earnings Report Earnings Call Summary Earnings Audio Slide Deck

GB:0HNC Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

GB:0HNC Earnings History

GB:0HNC earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release	Slides	Play Transcript
Feb 24, 2027	2026 (Q4)	0.82-	-0.24	―	―	―	―
Nov 02, 2026	2026 (Q3)	-0.050.23	-0.16	243.75% (+0.39)
Aug 06, 2026	2026 (Q2)	0.951.20	1.23	-2.44% (-0.03)
May 04, 2026	2026 (Q1)	0.690.76	0.95	-20.00% (-0.19)
Feb 23, 2026	2025 (Q4)	0.17-0.24	0.64	-137.50% (-0.88)
Oct 27, 2025	2025 (Q3)	-0.28-0.16	0.55	-129.09% (-0.71)
Aug 04, 2025	2025 (Q2)	0.861.23	0.55	123.64% (+0.68)
May 01, 2025	2025 (Q1)	0.710.95	0.46	106.52% (+0.49)
Feb 19, 2025	2024 (Q4)	0.530.64	0.11	481.82% (+0.53)
Oct 29, 2024	2024 (Q3)	0.530.55	0.21	161.90% (+0.34)
Aug 05, 2024	2024 (Q2)	0.360.55	0.29	89.66% (+0.26)
Apr 24, 2024	2024 (Q1)	0.310.46	0.27	70.37% (+0.19)
Feb 22, 2024	2023 (Q4)	0.200.11	0	―
Nov 01, 2023	2023 (Q3)	0.220.21	-0.04	625.00% (+0.25)
Jul 31, 2023	2023 (Q2)	0.210.29	0.15	93.33% (+0.14)
Apr 26, 2023	2023 (Q1)	0.150.27	0.63	-57.14% (-0.36)
Feb 27, 2023	2022 (Q4)	-0.060.00	-0.32	100.00% (+0.32)
Oct 26, 2022	2022 (Q3)	-0.01-0.04	-0.2	80.00% (+0.16)		―
Aug 03, 2022	2022 (Q2)	0.030.15	0.07	114.29% (+0.08)		―	―
Apr 27, 2022	2022 (Q1)	0.210.63	0.09	600.00% (+0.54)		―	―
Feb 23, 2022	2021 (Q4)	-0.36-0.32	0.12	-366.67% (-0.44)		―	―
Oct 27, 2021	2021 (Q3)	-0.25-0.20	4.01	-104.99% (-4.21)		―	―
Jul 28, 2021	2021 (Q2)	-0.110.07	-0.16	143.75% (+0.23)		―	―
Apr 29, 2021	2021 (Q1)	―0.09	0.44	-79.55% (-0.35)		―	―
Feb 25, 2021	2020 (Q4)	―0.12	0.08	50.00% (+0.04)		―	―
Nov 05, 2020	2020 (Q3)	―4.01	0.3	1236.67% (+3.71)		―	―
Aug 04, 2020	2020 (Q2)	―-0.16	-0.21	23.81% (+0.05)		―	―
Apr 29, 2020	2020 (Q1)	―0.44	-0.32	237.50% (+0.76)		―	―
Feb 26, 2020	2019 (Q4)	―0.08	-0.03	366.67% (+0.11)		―	―
Oct 23, 2019	2019 (Q3)	―0.30	-0.07	528.57% (+0.37)		―	―
Aug 01, 2019	2019 (Q2)	―-0.21	-0.09	-133.33% (-0.12)		―	―
Apr 25, 2019	2019 (Q1)	―-0.32	-0.26	-23.08% (-0.06)		―	―
Feb 21, 2019	2018 (Q4)	―-0.03	-0.3	90.00% (+0.27)		―	―
Oct 25, 2018	2018 (Q3)	―-0.07	-0.07	0.00% (+0.00)		―	―
Aug 02, 2018	2018 (Q2)	―-0.09	-0.21	57.14% (+0.12)		―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.

Beat Missed

GB:0HNC Earnings-Related Price Changes

GB:0HNC earnings price reaction
Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 02, 2026	$58.15	$55.08	-5.28%
Aug 06, 2026	$59.68	$63.30	+6.07%
May 04, 2026	$54.97	$53.20	-3.22%
Feb 23, 2026	$63.97	$62.58	-2.17%
Oct 27, 2025	$53.77	$53.78	+0.02%
Aug 04, 2025	$60.41	$62.96	+4.23%
May 01, 2025	$63.10	$62.08	-1.62%
Feb 19, 2025	$64.95	$68.92	+6.11%
Oct 29, 2024	$69.54	$67.33	-3.17%
Aug 05, 2024	$81.25	$87.03	+7.11%
Apr 24, 2024	$91.49	$83.32	-8.93%
Feb 22, 2024	$89.73	$91.81	+2.32%
Nov 01, 2023	$83.68	$79.67	-4.79%
Jul 31, 2023	$87.49	$88.28	+0.90%
Apr 26, 2023	$93.47	$89.98	-3.73%
Feb 27, 2023	$103.62	$100.05	-3.45%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.

FAQ

When does BioMarin Pharmaceutical (GB:0HNC) report earnings?

BioMarin Pharmaceutical (GB:0HNC) is estimated to report earnings on Feb 24, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.

What is GB:0HNC EPS forecast?

GB:0HNC EPS forecast for the fiscal quarter 2026 (Q4) is 0.82.

BioMarin Pharmaceutical (GB:0HNC) Earnings News

Market NewsBioMarin (NASDAQ:BMRN) Gains after Elliott Investment Picks Up Stake3y agoBMRN

See More GB:0HNC News >

BioMarin Pharmaceutical earnings date